

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 7.50265831 |
| 2 | doxorubicin metabolic process (GO:0044598) | 7.50265831 |
| 3 | daunorubicin metabolic process (GO:0044597) | 7.50265831 |
| 4 | axonemal dynein complex assembly (GO:0070286) | 6.51887734 |
| 5 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.12227419 |
| 6 | motile cilium assembly (GO:0044458) | 5.34311403 |
| 7 | cilium movement (GO:0003341) | 5.00324532 |
| 8 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.97014924 |
| 9 | response to dietary excess (GO:0002021) | 4.83294209 |
| 10 | semaphorin-plexin signaling pathway (GO:0071526) | 4.81314726 |
| 11 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.77444943 |
| 12 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.59666730 |
| 13 | maintenance of protein location in nucleus (GO:0051457) | 4.55063820 |
| 14 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 4.54791615 |
| 15 | establishment of apical/basal cell polarity (GO:0035089) | 4.21461464 |
| 16 | coenzyme catabolic process (GO:0009109) | 4.20304802 |
| 17 | cell migration in hindbrain (GO:0021535) | 4.14617970 |
| 18 | lung epithelium development (GO:0060428) | 4.11378665 |
| 19 | somite rostral/caudal axis specification (GO:0032525) | 4.04793051 |
| 20 | cytidine deamination (GO:0009972) | 3.98692375 |
| 21 | cytidine metabolic process (GO:0046087) | 3.98692375 |
| 22 | cytidine catabolic process (GO:0006216) | 3.98692375 |
| 23 | cellular modified amino acid catabolic process (GO:0042219) | 3.91335530 |
| 24 | synaptic vesicle maturation (GO:0016188) | 3.89895760 |
| 25 | regulation of response to osmotic stress (GO:0047484) | 3.87210639 |
| 26 | muscle organ morphogenesis (GO:0048644) | 3.85097201 |
| 27 | maintenance of protein localization in organelle (GO:0072595) | 3.79630030 |
| 28 | proline transport (GO:0015824) | 3.78750593 |
| 29 | hormone catabolic process (GO:0042447) | 3.77774454 |
| 30 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.77055790 |
| 31 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.65563366 |
| 32 | establishment of monopolar cell polarity (GO:0061162) | 3.65563366 |
| 33 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.64027030 |
| 34 | epithelial cilium movement (GO:0003351) | 3.62790120 |
| 35 | detection of temperature stimulus (GO:0016048) | 3.62769523 |
| 36 | negative regulation of cell size (GO:0045792) | 3.61899519 |
| 37 | protein targeting to Golgi (GO:0000042) | 3.60598614 |
| 38 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.60434020 |
| 39 | left/right pattern formation (GO:0060972) | 3.60130043 |
| 40 | cell-cell junction maintenance (GO:0045217) | 3.55559362 |
| 41 | thyroid hormone generation (GO:0006590) | 3.55426901 |
| 42 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.50438867 |
| 43 | ear development (GO:0043583) | 3.49799005 |
| 44 | axoneme assembly (GO:0035082) | 3.47847903 |
| 45 | apical protein localization (GO:0045176) | 3.42092942 |
| 46 | phenol-containing compound catabolic process (GO:0019336) | 3.41650848 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.37310460 |
| 48 | mannose metabolic process (GO:0006013) | 3.37193658 |
| 49 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.34007456 |
| 50 | GDP-mannose metabolic process (GO:0019673) | 3.32766001 |
| 51 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.32422190 |
| 52 | protein palmitoylation (GO:0018345) | 3.30915655 |
| 53 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.29733872 |
| 54 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.28371998 |
| 55 | creatine metabolic process (GO:0006600) | 3.26088585 |
| 56 | arachidonic acid secretion (GO:0050482) | 3.25241190 |
| 57 | icosanoid secretion (GO:0032309) | 3.25241190 |
| 58 | endothelial cell chemotaxis (GO:0035767) | 3.24793624 |
| 59 | convergent extension (GO:0060026) | 3.24631881 |
| 60 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.24174290 |
| 61 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.21531326 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15054809 |
| 63 | regulation of establishment of planar polarity (GO:0090175) | 3.13877251 |
| 64 | regulation of ARF GTPase activity (GO:0032312) | 3.10941526 |
| 65 | negative regulation of complement activation (GO:0045916) | 3.10639551 |
| 66 | ventricular system development (GO:0021591) | 3.09483884 |
| 67 | establishment of protein localization to Golgi (GO:0072600) | 3.08009619 |
| 68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.07565782 |
| 69 | nucleoside transmembrane transport (GO:1901642) | 3.05468990 |
| 70 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.04586630 |
| 71 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00573460 |
| 72 | negative regulation of humoral immune response (GO:0002921) | 2.98772966 |
| 73 | cerebellar granule cell differentiation (GO:0021707) | 2.98163246 |
| 74 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.96968624 |
| 75 | peptidyl-cysteine modification (GO:0018198) | 2.96133814 |
| 76 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.95489083 |
| 77 | tachykinin receptor signaling pathway (GO:0007217) | 2.91321679 |
| 78 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.91090433 |
| 79 | COPI coating of Golgi vesicle (GO:0048205) | 2.91084888 |
| 80 | Golgi transport vesicle coating (GO:0048200) | 2.91084888 |
| 81 | mitochondrion distribution (GO:0048311) | 2.88801688 |
| 82 | positive regulation of protein kinase C signaling (GO:0090037) | 2.88715874 |
| 83 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.85987331 |
| 84 | intestinal epithelial cell development (GO:0060576) | 2.84308123 |
| 85 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.83441241 |
| 86 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.82818555 |
| 87 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.82818555 |
| 88 | collecting duct development (GO:0072044) | 2.81956608 |
| 89 | sulfur amino acid catabolic process (GO:0000098) | 2.80024458 |
| 90 | negative regulation of epidermis development (GO:0045683) | 2.79004338 |
| 91 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.78606544 |
| 92 | mitochondrion transport along microtubule (GO:0047497) | 2.78606544 |
| 93 | cell junction maintenance (GO:0034331) | 2.78404942 |
| 94 | neuronal ion channel clustering (GO:0045161) | 2.78304481 |
| 95 | regulation of autophagic vacuole assembly (GO:2000785) | 2.78058695 |
| 96 | protein-DNA complex disassembly (GO:0032986) | 2.75387191 |
| 97 | nucleosome disassembly (GO:0006337) | 2.75387191 |
| 98 | protein retention in ER lumen (GO:0006621) | 2.74981846 |
| 99 | microtubule bundle formation (GO:0001578) | 2.74543754 |
| 100 | camera-type eye morphogenesis (GO:0048593) | 2.73788046 |
| 101 | stress granule assembly (GO:0034063) | 2.72346048 |
| 102 | histone H4 deacetylation (GO:0070933) | 2.71300514 |
| 103 | valine metabolic process (GO:0006573) | 2.70912340 |
| 104 | quinone metabolic process (GO:1901661) | 2.70445092 |
| 105 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.70173336 |
| 106 | asymmetric protein localization (GO:0008105) | 2.69858629 |
| 107 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.66479345 |
| 108 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.66166355 |
| 109 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.66024104 |
| 110 | thyroid hormone metabolic process (GO:0042403) | 2.65249266 |
| 111 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.64858617 |
| 112 | regulation of microtubule-based movement (GO:0060632) | 2.64321414 |
| 113 | vocalization behavior (GO:0071625) | 2.63690247 |
| 114 | biotin metabolic process (GO:0006768) | 2.61662151 |
| 115 | histone H3-K9 demethylation (GO:0033169) | 2.61093130 |
| 116 | vitamin transmembrane transport (GO:0035461) | 2.60521142 |
| 117 | cardiovascular system development (GO:0072358) | 2.59986404 |
| 118 | phenylpropanoid metabolic process (GO:0009698) | 2.59027759 |
| 119 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.58871220 |
| 120 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.58871220 |
| 121 | dopamine receptor signaling pathway (GO:0007212) | 2.58374614 |
| 122 | neural tube development (GO:0021915) | 2.56412061 |
| 123 | rRNA transcription (GO:0009303) | 2.56219175 |
| 124 | thyroid gland development (GO:0030878) | 2.55543882 |
| 125 | cell volume homeostasis (GO:0006884) | 2.55125025 |
| 126 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.54162634 |
| 127 | establishment of mitochondrion localization (GO:0051654) | 2.53631489 |
| 128 | histone H3 deacetylation (GO:0070932) | 2.53592569 |
| 129 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.53569350 |
| 130 | non-canonical Wnt signaling pathway (GO:0035567) | 2.53413073 |
| 131 | gamma-aminobutyric acid transport (GO:0015812) | 2.53305234 |
| 132 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.52207761 |
| 133 | establishment of planar polarity (GO:0001736) | 2.52091261 |
| 134 | establishment of tissue polarity (GO:0007164) | 2.52091261 |
| 135 | negative regulation of protein activation cascade (GO:2000258) | 2.51281572 |
| 136 | icosanoid transport (GO:0071715) | 2.50199112 |
| 137 | fatty acid derivative transport (GO:1901571) | 2.50199112 |
| 138 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.50099187 |
| 139 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.49986844 |
| 140 | maternal placenta development (GO:0001893) | 2.48925264 |
| 141 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.47961426 |
| 142 | regulation of ARF protein signal transduction (GO:0032012) | 2.47905969 |
| 143 | positive regulation of digestive system process (GO:0060456) | 2.47580551 |
| 144 | regulation of chromatin binding (GO:0035561) | 2.45804171 |
| 145 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.45735062 |
| 146 | vitamin A metabolic process (GO:0006776) | 2.45448955 |
| 147 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.45371299 |
| 148 | positive regulation of synapse maturation (GO:0090129) | 2.44976350 |
| 149 | interferon-gamma production (GO:0032609) | 2.42580492 |
| 150 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.42112303 |
| 151 | establishment of melanosome localization (GO:0032401) | 2.41738097 |
| 152 | toxin metabolic process (GO:0009404) | 2.40654569 |
| 153 | adherens junction assembly (GO:0034333) | 2.40273524 |
| 154 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.39701605 |
| 155 | adaptation of signaling pathway (GO:0023058) | 2.39548533 |
| 156 | central nervous system myelination (GO:0022010) | 2.38961480 |
| 157 | axon ensheathment in central nervous system (GO:0032291) | 2.38961480 |
| 158 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.38342378 |
| 159 | myelin maintenance (GO:0043217) | 2.37412197 |
| 160 | histone lysine demethylation (GO:0070076) | 2.37010704 |
| 161 | regulation of vacuole organization (GO:0044088) | 2.36771019 |
| 162 | lateral sprouting from an epithelium (GO:0060601) | 2.34263613 |
| 163 | neutral amino acid transport (GO:0015804) | 2.33884650 |
| 164 | protein maturation by protein folding (GO:0022417) | 2.33289027 |
| 165 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.32601651 |
| 166 | toxin transport (GO:1901998) | 2.32458298 |
| 167 | melanosome transport (GO:0032402) | 2.32435717 |
| 168 | metanephric nephron epithelium development (GO:0072243) | 2.32015068 |
| 169 | primitive streak formation (GO:0090009) | 2.31988150 |
| 170 | negative regulation of telomerase activity (GO:0051974) | 2.31815479 |
| 171 | nerve growth factor signaling pathway (GO:0038180) | 2.31704965 |
| 172 | positive regulation of histone deacetylation (GO:0031065) | 2.30006466 |
| 173 | atrioventricular valve morphogenesis (GO:0003181) | 2.29683499 |
| 174 | protein localization to Golgi apparatus (GO:0034067) | 2.29521244 |
| 175 | phosphatidylserine metabolic process (GO:0006658) | 2.28040174 |
| 176 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.27686161 |
| 177 | axon extension involved in axon guidance (GO:0048846) | 2.27686161 |
| 178 | microtubule severing (GO:0051013) | 2.26907665 |
| 179 | diol metabolic process (GO:0034311) | 2.26731267 |
| 180 | apoptotic process involved in morphogenesis (GO:0060561) | 2.26678144 |
| 181 | negative regulation of interleukin-2 production (GO:0032703) | 2.26573762 |
| 182 | facial nerve structural organization (GO:0021612) | 2.26279614 |
| 183 | neuron projection regeneration (GO:0031102) | 2.26259649 |
| 184 | left/right axis specification (GO:0070986) | 2.25524157 |
| 185 | nucleoside transport (GO:0015858) | 2.25170318 |
| 186 | macroautophagy (GO:0016236) | 2.24686703 |
| 187 | establishment of pigment granule localization (GO:0051905) | 2.24634357 |
| 188 | neural tube closure (GO:0001843) | 2.24501675 |
| 189 | receptor clustering (GO:0043113) | 2.24487474 |
| 190 | histone H4-K5 acetylation (GO:0043981) | 2.23811171 |
| 191 | epithelial cell-cell adhesion (GO:0090136) | 2.21740728 |
| 192 | metanephric tubule development (GO:0072170) | 2.21365296 |
| 193 | metanephric nephron tubule development (GO:0072234) | 2.21365296 |
| 194 | tube closure (GO:0060606) | 2.20756024 |
| 195 | locomotory exploration behavior (GO:0035641) | 2.20305617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.77671551 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.04368381 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.04368381 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.04368381 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.91717231 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.91438500 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.21328148 |
| 8 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17990880 |
| 9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02917897 |
| 10 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.02740579 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01533333 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.99186623 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97193176 |
| 14 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.95347576 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94911424 |
| 16 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.91241546 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.89498409 |
| 18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.85520144 |
| 19 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.85485126 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.85197656 |
| 21 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.84119450 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82502519 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78329333 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77230670 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75863059 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74575739 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74247413 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70649781 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.69434934 |
| 30 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67064134 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.65773967 |
| 32 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64153578 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59836127 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59836127 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58573027 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.58444289 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58151871 |
| 38 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56064460 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.55483577 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51785393 |
| 41 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51140811 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49122791 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.48984251 |
| 44 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.45994294 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43614246 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.42180856 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41462351 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40812513 |
| 49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.38346684 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38176700 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37413953 |
| 52 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34699556 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33801941 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33550029 |
| 55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32766240 |
| 56 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31948038 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30932587 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30394040 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30387918 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30178339 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29911448 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.28986519 |
| 63 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.28371976 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26748977 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26386172 |
| 66 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26073401 |
| 67 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.23744157 |
| 68 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23167401 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20372526 |
| 70 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.19411432 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18713315 |
| 72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18553669 |
| 73 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17746302 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17140900 |
| 75 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.16024826 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.15723853 |
| 77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15427238 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14515161 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14329421 |
| 80 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.14309265 |
| 81 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.12100344 |
| 82 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11897830 |
| 83 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.10871302 |
| 84 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.10696416 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09874003 |
| 86 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09694385 |
| 87 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.09363470 |
| 88 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08870997 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07556766 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06904802 |
| 91 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06357736 |
| 92 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.05323357 |
| 93 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05308109 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05040929 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04766107 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04383350 |
| 97 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.02744647 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02369193 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02312768 |
| 100 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01839110 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00877838 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00595189 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00344278 |
| 104 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.00144968 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00065165 |
| 106 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99745107 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99427168 |
| 108 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.99178462 |
| 109 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99004206 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98673774 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98648477 |
| 112 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98584649 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98431911 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98331638 |
| 115 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.98228467 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98018230 |
| 117 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97418856 |
| 118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97325874 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97211783 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97049783 |
| 121 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.96926948 |
| 122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96844471 |
| 123 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.96809199 |
| 124 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96262643 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.96249651 |
| 126 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95622612 |
| 127 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95529049 |
| 128 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.94954336 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 0.94906758 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94782669 |
| 131 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94162052 |
| 132 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93930152 |
| 133 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92687965 |
| 134 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.91427212 |
| 135 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.91291066 |
| 136 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90381340 |
| 137 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89786926 |
| 138 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.88386661 |
| 139 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87968658 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87735533 |
| 141 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.87682771 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86319854 |
| 143 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85836118 |
| 144 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85836118 |
| 145 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85669472 |
| 146 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84693103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004858_abnormal_nervous_system | 4.54032544 |
| 2 | MP0002254_reproductive_system_inflammat | 4.28850174 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.49352980 |
| 4 | MP0003183_abnormal_peptide_metabolism | 3.32183285 |
| 5 | MP0003122_maternal_imprinting | 3.30544718 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.19221356 |
| 7 | MP0004043_abnormal_pH_regulation | 3.18223008 |
| 8 | MP0002249_abnormal_larynx_morphology | 3.17213883 |
| 9 | MP0009278_abnormal_bone_marrow | 2.99038463 |
| 10 | MP0003011_delayed_dark_adaptation | 2.98303067 |
| 11 | MP0002909_abnormal_adrenal_gland | 2.93583594 |
| 12 | MP0000566_synostosis | 2.85162669 |
| 13 | MP0000681_abnormal_thyroid_gland | 2.80644670 |
| 14 | MP0002822_catalepsy | 2.70070172 |
| 15 | MP0003878_abnormal_ear_physiology | 2.58518298 |
| 16 | MP0005377_hearing/vestibular/ear_phenot | 2.58518298 |
| 17 | MP0004133_heterotaxia | 2.43451360 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.43067803 |
| 19 | MP0005076_abnormal_cell_differentiation | 2.25245036 |
| 20 | MP0001348_abnormal_lacrimal_gland | 2.20791547 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.19522278 |
| 22 | MP0000749_muscle_degeneration | 2.18656938 |
| 23 | MP0008961_abnormal_basal_metabolism | 2.16418052 |
| 24 | MP0004270_analgesia | 2.12876806 |
| 25 | MP0000383_abnormal_hair_follicle | 2.07725420 |
| 26 | MP0002332_abnormal_exercise_endurance | 2.03583555 |
| 27 | MP0005394_taste/olfaction_phenotype | 1.94966251 |
| 28 | MP0005499_abnormal_olfactory_system | 1.94966251 |
| 29 | MP0005409_darkened_coat_color | 1.86397373 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.81245521 |
| 31 | MP0006292_abnormal_olfactory_placode | 1.75655091 |
| 32 | MP0001502_abnormal_circadian_rhythm | 1.73212279 |
| 33 | MP0005310_abnormal_salivary_gland | 1.69079044 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.61740244 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.57759201 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.53842322 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.52377893 |
| 38 | MP0003329_amyloid_beta_deposits | 1.51512834 |
| 39 | MP0004084_abnormal_cardiac_muscle | 1.50067849 |
| 40 | MP0001849_ear_inflammation | 1.49253579 |
| 41 | MP0003890_abnormal_embryonic-extraembry | 1.47630530 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.44710549 |
| 43 | MP0006082_CNS_inflammation | 1.44172706 |
| 44 | MP0002269_muscular_atrophy | 1.42061556 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.41181976 |
| 46 | MP0004036_abnormal_muscle_relaxation | 1.36236902 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.34468398 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.32525460 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.32508040 |
| 50 | MP0001984_abnormal_olfaction | 1.32052331 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 1.31614291 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.29996363 |
| 53 | MP0000920_abnormal_myelination | 1.29869801 |
| 54 | MP0002116_abnormal_craniofacial_bone | 1.26273155 |
| 55 | MP0003942_abnormal_urinary_system | 1.25407683 |
| 56 | MP0000955_abnormal_spinal_cord | 1.22946461 |
| 57 | MP0002064_seizures | 1.22141043 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.21547133 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.21106603 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 1.20347535 |
| 61 | MP0003861_abnormal_nervous_system | 1.20172624 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.19714681 |
| 63 | MP0003136_yellow_coat_color | 1.17243923 |
| 64 | MP0005330_cardiomyopathy | 1.16584340 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.15835834 |
| 66 | MP0003787_abnormal_imprinting | 1.14965217 |
| 67 | MP0000026_abnormal_inner_ear | 1.14882639 |
| 68 | MP0001188_hyperpigmentation | 1.14655528 |
| 69 | MP0000750_abnormal_muscle_regeneration | 1.14271424 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 1.14265802 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.13082732 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.11865188 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.10377563 |
| 74 | MP0003283_abnormal_digestive_organ | 1.09189952 |
| 75 | MP0003634_abnormal_glial_cell | 1.08832345 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.08160354 |
| 77 | MP0009046_muscle_twitch | 1.07751753 |
| 78 | MP0009672_abnormal_birth_weight | 1.07547656 |
| 79 | MP0000604_amyloidosis | 1.06252505 |
| 80 | MP0002733_abnormal_thermal_nociception | 1.04484476 |
| 81 | MP0004142_abnormal_muscle_tone | 1.03513440 |
| 82 | MP0002272_abnormal_nervous_system | 1.01990345 |
| 83 | MP0005666_abnormal_adipose_tissue | 1.01785635 |
| 84 | MP0002184_abnormal_innervation | 1.01122756 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 1.00768234 |
| 86 | MP0004085_abnormal_heartbeat | 1.00629875 |
| 87 | MP0000759_abnormal_skeletal_muscle | 1.00073622 |
| 88 | MP0000003_abnormal_adipose_tissue | 1.00005404 |
| 89 | MP0000428_abnormal_craniofacial_morphol | 0.99780171 |
| 90 | MP0002152_abnormal_brain_morphology | 0.98848946 |
| 91 | MP0003879_abnormal_hair_cell | 0.98663297 |
| 92 | MP0000462_abnormal_digestive_system | 0.97497538 |
| 93 | MP0001486_abnormal_startle_reflex | 0.96192832 |
| 94 | MP0004087_abnormal_muscle_fiber | 0.95997144 |
| 95 | MP0001270_distended_abdomen | 0.95214889 |
| 96 | MP0002877_abnormal_melanocyte_morpholog | 0.95193472 |
| 97 | MP0003115_abnormal_respiratory_system | 0.94445375 |
| 98 | MP0003075_altered_response_to | 0.94178902 |
| 99 | MP0003121_genomic_imprinting | 0.93757083 |
| 100 | MP0000049_abnormal_middle_ear | 0.92997827 |
| 101 | MP0005058_abnormal_lysosome_morphology | 0.92025240 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.91735658 |
| 103 | MP0008569_lethality_at_weaning | 0.91189297 |
| 104 | MP0001970_abnormal_pain_threshold | 0.91156464 |
| 105 | MP0004381_abnormal_hair_follicle | 0.90798531 |
| 106 | MP0003119_abnormal_digestive_system | 0.88059165 |
| 107 | MP0008260_abnormal_autophagy | 0.87602476 |
| 108 | MP0002970_abnormal_white_adipose | 0.86891673 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.86879082 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.86879082 |
| 111 | MP0002078_abnormal_glucose_homeostasis | 0.85738313 |
| 112 | MP0002734_abnormal_mechanical_nocicepti | 0.84978290 |
| 113 | MP0003690_abnormal_glial_cell | 0.84607108 |
| 114 | MP0004885_abnormal_endolymph | 0.84589740 |
| 115 | MP0005266_abnormal_metabolism | 0.83011801 |
| 116 | MP0002063_abnormal_learning/memory/cond | 0.82487870 |
| 117 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81655189 |
| 118 | MP0003123_paternal_imprinting | 0.80760128 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.79514418 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.79203502 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.79111549 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.78800850 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.78607382 |
| 124 | MP0002092_abnormal_eye_morphology | 0.78331774 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.77849864 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.76795802 |
| 127 | MP0003279_aneurysm | 0.76651082 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.76631444 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.76526273 |
| 130 | MP0001968_abnormal_touch/_nociception | 0.76119823 |
| 131 | MP0009703_decreased_birth_body | 0.74660183 |
| 132 | MP0001440_abnormal_grooming_behavior | 0.73648830 |
| 133 | MP0006138_congestive_heart_failure | 0.73382608 |
| 134 | MP0009745_abnormal_behavioral_response | 0.73165684 |
| 135 | MP0005646_abnormal_pituitary_gland | 0.72791941 |
| 136 | MP0000751_myopathy | 0.72741607 |
| 137 | MP0004510_myositis | 0.72409933 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.72000458 |
| 139 | MP0005083_abnormal_biliary_tract | 0.71197462 |
| 140 | MP0002796_impaired_skin_barrier | 0.71189238 |
| 141 | MP0000579_abnormal_nail_morphology | 0.70903688 |
| 142 | MP0005452_abnormal_adipose_tissue | 0.69989478 |
| 143 | MP0002972_abnormal_cardiac_muscle | 0.69098590 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.68059112 |
| 145 | MP0005535_abnormal_body_temperature | 0.67772379 |
| 146 | MP0002229_neurodegeneration | 0.66684409 |
| 147 | MP0002882_abnormal_neuron_morphology | 0.66131817 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.65317106 |
| 149 | MP0000778_abnormal_nervous_system | 0.64168302 |
| 150 | MP0006036_abnormal_mitochondrial_physio | 0.63445092 |
| 151 | MP0000762_abnormal_tongue_morphology | 0.63426010 |
| 152 | MP0002932_abnormal_joint_morphology | 0.62979060 |
| 153 | MP0000013_abnormal_adipose_tissue | 0.62948037 |
| 154 | MP0004185_abnormal_adipocyte_glucose | 0.62858662 |
| 155 | MP0005379_endocrine/exocrine_gland_phen | 0.62284882 |
| 156 | MP0005253_abnormal_eye_physiology | 0.61442683 |
| 157 | MP0004233_abnormal_muscle_weight | 0.61431416 |
| 158 | MP0005620_abnormal_muscle_contractility | 0.61393147 |
| 159 | MP0002090_abnormal_vision | 0.60693794 |
| 160 | MP0002106_abnormal_muscle_physiology | 0.60577253 |
| 161 | MP0002066_abnormal_motor_capabilities/c | 0.59484271 |
| 162 | MP0003938_abnormal_ear_development | 0.59123002 |
| 163 | MP0002752_abnormal_somatic_nervous | 0.58839635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.52536505 |
| 2 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.33009577 |
| 3 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.33009577 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.11821937 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 5.11821937 |
| 6 | Bilateral microphthalmos (HP:0007633) | 5.02510100 |
| 7 | Obstructive sleep apnea (HP:0002870) | 4.98639828 |
| 8 | Abnormal ciliary motility (HP:0012262) | 4.91035045 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.83803902 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.67463305 |
| 11 | Hepatoblastoma (HP:0002884) | 4.55729887 |
| 12 | Rhinitis (HP:0012384) | 4.17697165 |
| 13 | Multiple enchondromatosis (HP:0005701) | 4.08609946 |
| 14 | Chronic bronchitis (HP:0004469) | 3.95820117 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 3.78442990 |
| 16 | Broad face (HP:0000283) | 3.70989383 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55326952 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55326952 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55326952 |
| 20 | Bronchomalacia (HP:0002780) | 3.44520103 |
| 21 | Hyperacusis (HP:0010780) | 3.34385426 |
| 22 | Difficulty running (HP:0009046) | 3.32257146 |
| 23 | J-shaped sella turcica (HP:0002680) | 3.32031332 |
| 24 | Failure to thrive in infancy (HP:0001531) | 3.15473931 |
| 25 | Cervical subluxation (HP:0003308) | 3.14175151 |
| 26 | Testicular atrophy (HP:0000029) | 3.06809534 |
| 27 | Atelectasis (HP:0100750) | 3.05805479 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.03834202 |
| 29 | Generalized hypotonia (HP:0001290) | 3.02358080 |
| 30 | Bronchiectasis (HP:0002110) | 3.00587182 |
| 31 | Neoplasm of the heart (HP:0100544) | 2.98509999 |
| 32 | Hypochromic microcytic anemia (HP:0004840) | 2.95336454 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.92677125 |
| 34 | Ragged-red muscle fibers (HP:0003200) | 2.90313927 |
| 35 | Partial duplication of thumb phalanx (HP:0009944) | 2.89543651 |
| 36 | Bell-shaped thorax (HP:0001591) | 2.86795495 |
| 37 | Lymphangioma (HP:0100764) | 2.82541806 |
| 38 | Hyperventilation (HP:0002883) | 2.81640450 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80935501 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.78351882 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.78072768 |
| 42 | Rib fusion (HP:0000902) | 2.73435213 |
| 43 | Hand muscle atrophy (HP:0009130) | 2.72735353 |
| 44 | Stridor (HP:0010307) | 2.71653816 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.70266318 |
| 46 | Abnormality of the salivary glands (HP:0010286) | 2.67561151 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.66611695 |
| 48 | Distal upper limb amyotrophy (HP:0007149) | 2.62563164 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.62563164 |
| 50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.60353358 |
| 51 | Sleep apnea (HP:0010535) | 2.56618899 |
| 52 | Achilles tendon contracture (HP:0001771) | 2.51508053 |
| 53 | Amyotrophic lateral sclerosis (HP:0007354) | 2.48761333 |
| 54 | Ketoacidosis (HP:0001993) | 2.48520853 |
| 55 | Hemiparesis (HP:0001269) | 2.47455963 |
| 56 | Flat acetabular roof (HP:0003180) | 2.47227480 |
| 57 | Amblyopia (HP:0000646) | 2.45807924 |
| 58 | Sensory axonal neuropathy (HP:0003390) | 2.43781638 |
| 59 | Abnormality of the musculature of the hand (HP:0001421) | 2.41414169 |
| 60 | Abnormal cartilage morphology (HP:0002763) | 2.39848369 |
| 61 | Partial duplication of the phalanx of hand (HP:0009999) | 2.38770428 |
| 62 | Villous atrophy (HP:0011473) | 2.38171409 |
| 63 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.38171409 |
| 64 | Occipital encephalocele (HP:0002085) | 2.37010861 |
| 65 | Gout (HP:0001997) | 2.35838074 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.35392836 |
| 67 | Turricephaly (HP:0000262) | 2.32669125 |
| 68 | Vitreoretinal degeneration (HP:0000655) | 2.31924215 |
| 69 | Hypoplasia of the fovea (HP:0007750) | 2.29588435 |
| 70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.29588435 |
| 71 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.29302009 |
| 72 | Difficulty walking (HP:0002355) | 2.28850195 |
| 73 | Nuclear cataract (HP:0100018) | 2.27512158 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 2.27296432 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.27295052 |
| 76 | Broad distal phalanx of finger (HP:0009836) | 2.25578002 |
| 77 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24399836 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23052580 |
| 79 | Hyperthyroidism (HP:0000836) | 2.21676000 |
| 80 | Abnormality of the fingertips (HP:0001211) | 2.20102268 |
| 81 | Tetraplegia (HP:0002445) | 2.18873989 |
| 82 | Vaginal fistula (HP:0004320) | 2.17307732 |
| 83 | Shallow orbits (HP:0000586) | 2.16867271 |
| 84 | Horizontal nystagmus (HP:0000666) | 2.16676024 |
| 85 | Myokymia (HP:0002411) | 2.15751620 |
| 86 | Skin nodule (HP:0200036) | 2.15518491 |
| 87 | Infertility (HP:0000789) | 2.14937018 |
| 88 | Rectovaginal fistula (HP:0000143) | 2.14875676 |
| 89 | Rectal fistula (HP:0100590) | 2.14875676 |
| 90 | Broad metatarsal (HP:0001783) | 2.14733294 |
| 91 | Metaphyseal cupping (HP:0003021) | 2.13369501 |
| 92 | Male infertility (HP:0003251) | 2.12860390 |
| 93 | Ependymoma (HP:0002888) | 2.12217317 |
| 94 | Goiter (HP:0000853) | 2.10663322 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.08792039 |
| 96 | Anomalous pulmonary venous return (HP:0010772) | 2.06889305 |
| 97 | Germ cell neoplasia (HP:0100728) | 2.06318566 |
| 98 | Ventricular tachycardia (HP:0004756) | 2.01236510 |
| 99 | Deformed sella turcica (HP:0002681) | 2.00965032 |
| 100 | Resting tremor (HP:0002322) | 1.98894500 |
| 101 | Thoracic kyphosis (HP:0002942) | 1.98844151 |
| 102 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98340122 |
| 103 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97958391 |
| 104 | Abnormality of the dental root (HP:0006486) | 1.97097748 |
| 105 | Taurodontia (HP:0000679) | 1.97097748 |
| 106 | Abnormality of permanent molar morphology (HP:0011071) | 1.97097748 |
| 107 | Bifid tongue (HP:0010297) | 1.96128750 |
| 108 | Recurrent otitis media (HP:0000403) | 1.95692715 |
| 109 | Exercise-induced myalgia (HP:0003738) | 1.95448722 |
| 110 | Ankle clonus (HP:0011448) | 1.95297543 |
| 111 | Epileptic encephalopathy (HP:0200134) | 1.95132127 |
| 112 | Malnutrition (HP:0004395) | 1.93933096 |
| 113 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93787647 |
| 114 | Abnormality of the thoracic spine (HP:0100711) | 1.92881770 |
| 115 | Hyperactive renin-angiotensin system (HP:0000841) | 1.91260164 |
| 116 | Thin bony cortex (HP:0002753) | 1.89243808 |
| 117 | Abnormality of the fovea (HP:0000493) | 1.89050041 |
| 118 | Abnormality of the aortic arch (HP:0012303) | 1.88739744 |
| 119 | Epiphyseal dysplasia (HP:0002656) | 1.87937854 |
| 120 | Reduced antithrombin III activity (HP:0001976) | 1.87568392 |
| 121 | Biconcave vertebral bodies (HP:0004586) | 1.87298770 |
| 122 | Open mouth (HP:0000194) | 1.87150086 |
| 123 | Intestinal fistula (HP:0100819) | 1.86955720 |
| 124 | Hypoplastic scapulae (HP:0000882) | 1.85675044 |
| 125 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.85675044 |
| 126 | Episodic fever (HP:0001954) | 1.85573904 |
| 127 | Renal salt wasting (HP:0000127) | 1.85139940 |
| 128 | Exercise-induced muscle cramps (HP:0003710) | 1.84183258 |
| 129 | Fused cervical vertebrae (HP:0002949) | 1.83929215 |
| 130 | Choanal stenosis (HP:0000452) | 1.82203997 |
| 131 | Genetic anticipation (HP:0003743) | 1.81646257 |
| 132 | Myoglobinuria (HP:0002913) | 1.81344969 |
| 133 | Aplastic anemia (HP:0001915) | 1.80863405 |
| 134 | Spastic gait (HP:0002064) | 1.80640834 |
| 135 | Visceral angiomatosis (HP:0100761) | 1.80402886 |
| 136 | Precocious puberty (HP:0000826) | 1.79789855 |
| 137 | Abnormality of cochlea (HP:0000375) | 1.79685003 |
| 138 | Abnormality of the dental pulp (HP:0006479) | 1.79436295 |
| 139 | Nasolacrimal duct obstruction (HP:0000579) | 1.78892933 |
| 140 | Abnormality of molar morphology (HP:0011070) | 1.78534919 |
| 141 | Abnormality of molar (HP:0011077) | 1.78534919 |
| 142 | Diminished motivation (HP:0000745) | 1.78195024 |
| 143 | Status epilepticus (HP:0002133) | 1.77907068 |
| 144 | Limb-girdle muscle atrophy (HP:0003797) | 1.75721965 |
| 145 | Pointed chin (HP:0000307) | 1.75438718 |
| 146 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74977037 |
| 147 | Tubulointerstitial nephritis (HP:0001970) | 1.73185622 |
| 148 | Increased connective tissue (HP:0009025) | 1.72451629 |
| 149 | Abnormal vertebral ossification (HP:0100569) | 1.71942981 |
| 150 | Ulnar bowing (HP:0003031) | 1.71499097 |
| 151 | Arnold-Chiari malformation (HP:0002308) | 1.71244614 |
| 152 | Cystic liver disease (HP:0006706) | 1.71123221 |
| 153 | Abnormality of glycolysis (HP:0004366) | 1.71120624 |
| 154 | Increased serum pyruvate (HP:0003542) | 1.71120624 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.70804449 |
| 156 | Shawl scrotum (HP:0000049) | 1.70636908 |
| 157 | Amyloidosis (HP:0011034) | 1.70388171 |
| 158 | Renovascular hypertension (HP:0100817) | 1.69930821 |
| 159 | Renal dysplasia (HP:0000110) | 1.69427635 |
| 160 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.68736907 |
| 161 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68365503 |
| 162 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68365503 |
| 163 | Aplasia involving bones of the extremities (HP:0009825) | 1.68365503 |
| 164 | Hemangiomatosis (HP:0007461) | 1.66823254 |
| 165 | Macroorchidism (HP:0000053) | 1.66284071 |
| 166 | Tracheal stenosis (HP:0002777) | 1.65935677 |
| 167 | EMG: neuropathic changes (HP:0003445) | 1.65755426 |
| 168 | Polycystic kidney dysplasia (HP:0000113) | 1.64257028 |
| 169 | Bronchitis (HP:0012387) | 1.64035119 |
| 170 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.63734785 |
| 171 | Mucopolysacchariduria (HP:0008155) | 1.63734785 |
| 172 | Myotonia (HP:0002486) | 1.62359574 |
| 173 | Supernumerary nipples (HP:0002558) | 1.62170462 |
| 174 | Overriding aorta (HP:0002623) | 1.61639585 |
| 175 | Apathy (HP:0000741) | 1.61611715 |
| 176 | Symptomatic seizures (HP:0011145) | 1.61537782 |
| 177 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.61305012 |
| 178 | Type I transferrin isoform profile (HP:0003642) | 1.61130817 |
| 179 | Nasal polyposis (HP:0100582) | 1.60432255 |
| 180 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.59883847 |
| 181 | Elfin facies (HP:0004428) | 1.59413173 |
| 182 | Hypoplasia of the odontoid process (HP:0003311) | 1.58362063 |
| 183 | Annular pancreas (HP:0001734) | 1.57608773 |
| 184 | Spinal canal stenosis (HP:0003416) | 1.57476275 |
| 185 | Severe Myopia (HP:0011003) | 1.57053655 |
| 186 | Aortic regurgitation (HP:0001659) | 1.56078888 |
| 187 | Morphological abnormality of the inner ear (HP:0011390) | 1.54770598 |
| 188 | Recurrent sinusitis (HP:0011108) | 1.54308912 |
| 189 | Broad phalanges of the hand (HP:0009768) | 1.54037966 |
| 190 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.53912991 |
| 191 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.53912991 |
| 192 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.53912991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.39210655 |
| 2 | GRK5 | 4.47240713 |
| 3 | CDK12 | 3.87151521 |
| 4 | GRK6 | 3.36543920 |
| 5 | SMG1 | 3.00571163 |
| 6 | EEF2K | 2.80248096 |
| 7 | TYRO3 | 2.73263401 |
| 8 | NTRK1 | 2.58352356 |
| 9 | PKN2 | 2.56508946 |
| 10 | EPHA2 | 2.31932642 |
| 11 | GRK7 | 2.22969231 |
| 12 | GRK1 | 2.19753172 |
| 13 | ADRBK2 | 2.16326431 |
| 14 | WNK1 | 2.01948985 |
| 15 | TNK2 | 1.96912847 |
| 16 | FGFR4 | 1.80081117 |
| 17 | RPS6KA2 | 1.79529336 |
| 18 | TRIB3 | 1.76746002 |
| 19 | MAP3K6 | 1.75524044 |
| 20 | NME1 | 1.71239860 |
| 21 | CSF1R | 1.67798427 |
| 22 | MAPK7 | 1.67246309 |
| 23 | FGFR2 | 1.65972214 |
| 24 | TGFBR2 | 1.56460467 |
| 25 | PHKG2 | 1.56361245 |
| 26 | PHKG1 | 1.56361245 |
| 27 | BCKDK | 1.51211919 |
| 28 | MAP3K9 | 1.50607198 |
| 29 | MATK | 1.50338629 |
| 30 | MARK2 | 1.45316617 |
| 31 | MOS | 1.44366761 |
| 32 | ERBB2 | 1.38119692 |
| 33 | INSRR | 1.34994477 |
| 34 | MTOR | 1.34510330 |
| 35 | CAMK4 | 1.28742541 |
| 36 | PRKD2 | 1.26902296 |
| 37 | RPS6KL1 | 1.24860904 |
| 38 | RPS6KC1 | 1.24860904 |
| 39 | EPHB1 | 1.22952747 |
| 40 | MAPK12 | 1.21467445 |
| 41 | LMTK2 | 1.21388726 |
| 42 | NTRK3 | 1.20612134 |
| 43 | AKT3 | 1.18719314 |
| 44 | DAPK2 | 1.17918372 |
| 45 | HIPK2 | 1.16901028 |
| 46 | ADRBK1 | 1.16534433 |
| 47 | CAMKK1 | 1.12936114 |
| 48 | TBK1 | 1.12593617 |
| 49 | CDC42BPA | 1.10437521 |
| 50 | MAP3K7 | 1.06688985 |
| 51 | STK39 | 1.05979547 |
| 52 | TTN | 1.04644913 |
| 53 | RPS6KA6 | 1.04454891 |
| 54 | PDGFRA | 1.02148212 |
| 55 | UHMK1 | 0.99656868 |
| 56 | MAP2K4 | 0.98824103 |
| 57 | PAK3 | 0.98448279 |
| 58 | PRKG2 | 0.96417740 |
| 59 | TAOK1 | 0.94518162 |
| 60 | WNK4 | 0.90060272 |
| 61 | PTK2 | 0.88953011 |
| 62 | DMPK | 0.88867320 |
| 63 | PRKCH | 0.86743027 |
| 64 | SIK1 | 0.86016855 |
| 65 | MAP2K3 | 0.82668482 |
| 66 | PAK6 | 0.82002767 |
| 67 | MAP2K6 | 0.79382410 |
| 68 | CDK19 | 0.79089206 |
| 69 | RPS6KB2 | 0.76864567 |
| 70 | EPHA4 | 0.74264191 |
| 71 | ITK | 0.73396926 |
| 72 | IRAK2 | 0.73187289 |
| 73 | KSR2 | 0.71844424 |
| 74 | MARK1 | 0.69682912 |
| 75 | MAP3K13 | 0.65348755 |
| 76 | SGK223 | 0.65060359 |
| 77 | SGK494 | 0.65060359 |
| 78 | MAPKAPK3 | 0.63938716 |
| 79 | PKN1 | 0.62028049 |
| 80 | TAOK3 | 0.61476591 |
| 81 | ROCK2 | 0.61038599 |
| 82 | LIMK1 | 0.60878105 |
| 83 | TAOK2 | 0.60220658 |
| 84 | DYRK1A | 0.59336200 |
| 85 | NEK6 | 0.58948542 |
| 86 | MAPK8 | 0.58057408 |
| 87 | RIPK1 | 0.57214424 |
| 88 | MAPK15 | 0.57185303 |
| 89 | FGFR3 | 0.55877180 |
| 90 | ICK | 0.55477579 |
| 91 | PTK6 | 0.55475236 |
| 92 | PAK4 | 0.55174976 |
| 93 | MAP3K2 | 0.54446893 |
| 94 | CDK5 | 0.54144703 |
| 95 | CHUK | 0.53853083 |
| 96 | MAPK10 | 0.53115748 |
| 97 | RPS6KA1 | 0.52929978 |
| 98 | LRRK2 | 0.52452608 |
| 99 | STK38 | 0.52342101 |
| 100 | PRPF4B | 0.52042214 |
| 101 | OXSR1 | 0.51475111 |
| 102 | PRKCZ | 0.49870618 |
| 103 | SGK3 | 0.49530494 |
| 104 | PDPK1 | 0.49331039 |
| 105 | PDK1 | 0.48594649 |
| 106 | MAP3K1 | 0.48234901 |
| 107 | ZAP70 | 0.47972761 |
| 108 | STK11 | 0.47950586 |
| 109 | RET | 0.46863484 |
| 110 | MAP3K11 | 0.46169888 |
| 111 | CSK | 0.45923449 |
| 112 | BCR | 0.45754746 |
| 113 | KDR | 0.45739272 |
| 114 | BMX | 0.45618693 |
| 115 | PRKD1 | 0.45208254 |
| 116 | NTRK2 | 0.45140169 |
| 117 | IKBKE | 0.44979505 |
| 118 | MYLK | 0.44880687 |
| 119 | DYRK1B | 0.43102513 |
| 120 | CAMK1D | 0.43077083 |
| 121 | JAK2 | 0.42951804 |
| 122 | SCYL2 | 0.42568121 |
| 123 | TESK1 | 0.41824546 |
| 124 | STK10 | 0.41588535 |
| 125 | INSR | 0.41133132 |
| 126 | CAMK1G | 0.40539997 |
| 127 | IGF1R | 0.40379237 |
| 128 | MAP2K2 | 0.39951879 |
| 129 | FES | 0.39656660 |
| 130 | MUSK | 0.39026671 |
| 131 | PRKACG | 0.38519441 |
| 132 | MAPK3 | 0.38421802 |
| 133 | PRKCI | 0.38390466 |
| 134 | PRKCD | 0.37767352 |
| 135 | SGK2 | 0.37460062 |
| 136 | GSK3B | 0.36596439 |
| 137 | MAP3K10 | 0.36484461 |
| 138 | DYRK2 | 0.36333962 |
| 139 | PRKD3 | 0.35883183 |
| 140 | LATS2 | 0.35701174 |
| 141 | CAMK1 | 0.35121600 |
| 142 | ARAF | 0.35060279 |
| 143 | MAPK1 | 0.34154534 |
| 144 | MET | 0.34015302 |
| 145 | DDR2 | 0.33155479 |
| 146 | PDGFRB | 0.31916705 |
| 147 | PRKACA | 0.31317062 |
| 148 | PRKAA1 | 0.31199001 |
| 149 | CDK15 | 0.29616374 |
| 150 | SRC | 0.29607451 |
| 151 | SIK2 | 0.29013519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.63202246 |
| 2 | Notch signaling pathway_Homo sapiens_hsa04330 | 3.20789585 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.46270460 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.29094741 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.14063308 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84685006 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62242845 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 1.52710081 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50962719 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 1.49157631 |
| 11 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.48929579 |
| 12 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.47275165 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46296014 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44343612 |
| 15 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.43535232 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36761531 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.35198743 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34412092 |
| 19 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.34129894 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33985585 |
| 21 | Tight junction_Homo sapiens_hsa04530 | 1.31780059 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.30863002 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29834140 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29674975 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28346550 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.28289943 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.28052869 |
| 28 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.27977690 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.27328776 |
| 30 | Melanogenesis_Homo sapiens_hsa04916 | 1.25950473 |
| 31 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.25020372 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22162177 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.20189841 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20121183 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19281503 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18994307 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.17746155 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16983109 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16032330 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15460015 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14742745 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.11733552 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11480702 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09996093 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07208697 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.07047862 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07045115 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06801106 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03349879 |
| 50 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02031305 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01665893 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00984582 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00333303 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97253950 |
| 55 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.96958656 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93536617 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93073810 |
| 58 | Glioma_Homo sapiens_hsa05214 | 0.91009952 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90903080 |
| 60 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.89951978 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89897710 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89679843 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.89032923 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87604358 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86876330 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85748137 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85284291 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84991594 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83868632 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81715725 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81620554 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81492918 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80985173 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80778258 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.80482162 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80082240 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.78323521 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.77779132 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77529259 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.77495240 |
| 81 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76461891 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74020235 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73729041 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73490564 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73395923 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71959969 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71575775 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71314099 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.71215713 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71161775 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.70903809 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.70757709 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70748970 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70201814 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69797663 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69486073 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69086545 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.69047767 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68658144 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66843471 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66658958 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66559752 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66318412 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66278064 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66176275 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65368066 |
| 107 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64603207 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64570341 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64449966 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64183812 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.63819366 |
| 112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63024990 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62540080 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62111165 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60837520 |
| 116 | Gap junction_Homo sapiens_hsa04540 | 0.60786776 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60698846 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.60506598 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60347491 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59861653 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59262563 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.58525585 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.58501536 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56680877 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56255045 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56080192 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55858282 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54358686 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54096249 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54086970 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53066784 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52953325 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.52596243 |
| 134 | Morphine addiction_Homo sapiens_hsa05032 | 0.52414230 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51526724 |
| 136 | Renin secretion_Homo sapiens_hsa04924 | 0.50332072 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49557398 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49049859 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.48988112 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48587894 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48498948 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47907272 |
| 143 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47712135 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47357410 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47073147 |
| 146 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46151314 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45790798 |
| 148 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45457389 |
| 149 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44528708 |
| 150 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44465728 |
| 151 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42961161 |

